Human gamma interferon production by leukocytes induced with monoclonal antibodies recognizing T cells. 1981

P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart

The murine monoclonal antibody OKT3 (IgG2), which recognizes the majority of human E-rosette-forming cells, was found to induce interferon (IFN) production in human peripheral lymphocytes in vitro. This IFN was classified as IFN-gamma by virtue of its acid stability, nonneutralization by antisera recognizing human IFN-alpha and beta, and non-cross-reactivity on bovine kidney cells. OKT3 elicited considerable IFN-gamma yields at a concentration of 1 ng/ml, at which only very low mitogenesis of the lymphocytes measured by 3H-thymidine incorporation was seen. The IFN-gamma activity appeared beginning 3 to 6 hr after stimulation and reached its maximum after 36 hr. Anti-human Lyt3, anti-human Lyt2, or anti-human Lyt1 monoclonal antibodies, recognizing all or the majority of the E-rosette-forming cells, did not elicit IFN-gamma production. The OKT4 monoclonal antibody, which defines a subpopulation of T cells containing cells with helper activity, induced marginal levels of IFN-gamma. In contrast, OKT8 monoclonal antibody (defining cytotoxic/suppressor cells) as well as monoclonal or heterologous antibodies recognizing histocompatibility antigens or surface immunoglobulin failed to induce IFN-gamma production. Heterologous anti-thymocyte globulin or anti-lymphocytic serum were effective IFN-gamma inducers. Cell separation studies of the leukocytes demonstrated that E-rosette-forming cells are responsible for production of IFN-gamma induced by OKT3. Treatment of the leukocyte suspension with OKt3 monoclonal antibody plus complement abolished IFN-gamma production induced by this antibody. These results demonstrate that the OKT3 antibody recognizing an antigen present on the majority of the E-rosette-forming cells alone is sufficient to induce IFN-gamma production. OKT3-positive cells are apparently the producers of this IFN-gamma.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart
January 1983, Medical microbiology and immunology,
P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart
October 1993, Immunology letters,
P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart
February 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart
January 1983, The EMBO journal,
P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart
February 1989, Transplantation proceedings,
P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart
January 1988, Virologie,
P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart
July 1996, European journal of immunology,
P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart
April 1987, Hybridoma,
P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart
November 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
P von Wussow, and C D Platsoucas, and M Wiranowska-Stewart, and W E Stewart
April 2003, Hybridoma and hybridomics,
Copied contents to your clipboard!